Jump to content

MaryO

~Chief Cushie~
  • Posts

    7,611
  • Joined

  • Last visited

  • Days Won

    320

MaryO last won the day on September 23

MaryO had the most liked content!

2 Followers

About MaryO

  • Birthday September 22

Contact Methods

  • Website URL
    https://cushingsbios.com
  • ICQ
    0

Profile Information

  • Gender
    Female
  • Location
    Northern Virginia
  • Interests
    My family, computers, music, reading, ice cream, handbells, the Internet, Chinese Food, chocolate, watching ice skating competitions, napping, piano duets, Kindle, iPad...in no particular order.

Recent Profile Visitors

36,126 profile views

MaryO's Achievements

Contributor

Contributor (5/14)

  • Dedicated Rare
  • Conversation Starter Rare
  • Reacting Well Rare
  • First Post Rare
  • Collaborator Rare

Recent Badges

672

Reputation

Single Status Update

See all updates by MaryO

  1. MEKT1 Could Be a Potential New Therapy for Treating Cushing’s Disease

    PPAR-γ agonists — agents that activate PPAR-γ — include the medications rosiglitazone and pioglitazone, both of which are used to treat type 2 diabetes. Some studies have shown that rosiglitazone and pioglitazone have an effect on Pomc suppression, which would lead to lower levels of ACTH and help treat patients with Cushing’s disease.

    However, the benefits of PPAR-γ agonists in the treatment of Cushing’s disease are still controversial.

    Read more at https://cushieblog.com/2018/08/02/mekt1-could-be-a-potential-new-therapy-for-treating-cushings-disease/

×
×
  • Create New...